Soluble RAGE in COPD, with or without coexisting obstructive sleep apnoea
Authors:
Open Access
- 21 June 2022
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 23 (1) , 1-9
Abstract
Background: Hypoxia can reduce the levels of soluble receptor for advanced glycation end-products (sRAGE), a new anti-inflammatory biomarker of COPD. We assessed sRAGE in patients with hypoxia-related diseases such as COPD, OSA and OSA-COPD overlap. Methods: Plasma levels of sRAGE were measured in 317 subjects at baseline (57 heathy nonsmokers [HNS], 84 healthy smokers [HS], 79 OSA, 62 COPD and 35 OSA-COPD overlap patients) and in 294 subjects after one year of follow-up (50 HNS, 74 HS, 77 OSA, 60 COPD and 33 overlap). Results: After adjusting for age, sex, smoking status and body mass index, sRAGE levels showed a reduction in OSA (− 12.5%, p = 0.005), COPD (− 14.8%, p < 0.001) and OSA-COPD overlap (− 12.3%, p = 0.02) compared with HNS. There were no differences when comparing sRAGE plasma levels between overlap patients and those with OSA or COPD alone. At follow-up, sRAGE levels did not change significantly in healthy subjects, COPD and OSA or OSA-COPD overlap nontreated with continuous positive airway pressure (CPAP). Moreover, in patients with OSA and OSA-COPD overlap who were treated with CPAP, sRAGE increased significantly. Conclusions: The levels of sRAGE are reduced in COPD and OSA. Treatment with CPAP appears to improve sRAGE levels in patients with OSA who also had COPD.Keywords
All Related Versions
Funding Information
- Instituto Salud Carlos III, Spanish Ministry of Health, Madrid, Spain (PI12/02175, PI15/01940 and PI18/01524, PI12/02175, PI15/01940 and PI18/01524, PI12/02175, PI15/01940 and PI18/01524, PI12/02175, PI15/01940 and PI18/01524, PI12/02175, PI15/01940 and PI18/01524)
This publication has 37 references indexed in Scilit:
- Fluorescent Advanced Glycation End Products and Their Soluble Receptor: The Birth of New Plasmatic Biomarkers for Risk Stratification of Acute Coronary SyndromePLOS ONE, 2013
- Sleep disorders in COPD: the forgotten dimensionEuropean Respiratory Review, 2013
- A Multisite Randomized Trial of Portable Sleep Studies and Positive Airway Pressure Autotitration Versus Laboratory-Based Polysomnography for the Diagnosis and Treatment of Obstructive Sleep Apnea: The HomePAP StudySLEEP, 2012
- Diagnóstico y tratamiento del síndrome de apneas-hipopneas del sueñoArchivos de Bronconeumología, 2011
- Hypoxia and InflammationNew England Journal of Medicine, 2011
- Biochemical oxidative stress-related markers in patients with obstructive sleep apneaMedical Science Monitor, 2011
- Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor- B in human osteoarthritis chondrocytesRheumatology, 2010
- Reduced soluble receptor for advanced glycation end-products in COPDEuropean Respiratory Journal, 2010
- Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trialThorax, 2008
- Standardisation of spirometryEuropean Respiratory Journal, 2005